|
Main | | | | |
| Name | Date | Size | Description |
| SterilMed | | | Reprocessing/reusable medtech. |
| RespiVert | 6/1/2010 | | Respiratory biotech/pharma. |
| Jontex (disposal) | 10/10/2009 | 221m | Sold Brazilian condom maker to Hypermarcas. |
| Cougar | | $1,000m | Prostate Cancer Phase III Candidate |
| Omrix | | | |
| Mentor | | | |
| Dabao | | | Chinese Cosmetics |
| SurgRx | | | |
| Conor Medsystems | 2/1/2007 | | CoStar cobalt chromium stent with fully bioabsorbable polymer |
| Pfizer Consumer Healthcare | 12/20/2006 | | |
| Ensure Medical | Q3 2006 | | post-catheterization closure of the femoral artery - clinical trials in early 2007 |
| Colbar Lifesciences | | $100m | Shutting down in 2009. |
| Groupe Vendome | Q1:06 | | French marketer of adult and baby skin care products |
| Vascular Control Systems | | | Medical devices to treat fibroids and control bleeding in obstetric and gynecologic applications. |
| Animas/Amicus? | 2/21/2006 | $518m | Leading maker of insulin infusion pumps. |
| Hand Innovations LLC | | | fracture fixation products for the upper extremities |
| Future Medical Systems SA | | | Arthroscopic Fluid Management systems |
| Guidant | Q3 2005 | | Failed acquisition, acquired by Boston Scientific. |
| TransForm Pharmaceuticals | | | Superior formulations and novel crystalline forms of drug molecules |
| Closure Medical | 2005 | $370m | Biosurgicals, Ethicon/EES businesses. |
| Peninsula | 2005 | | Antibiotic: doripenem. |
| Rembrandt | | | oral care |
| OraPharma | 2/1/2003 | | Arestin periodontal disease drug. |
| Axert marketing rights | 4/1/2003 | | Purchased from Almirall. |
| Alza | | | |
| Scios | | | |
| Tibotec | 2002 | | Antivirals: HIV, Hepatitis C, TB. |
| Centocor | | | |
| Finsbury Orthopaedics | | | |
| Gloster Europe | | | |
| Acclarent | | | |